Name | United Home Care |
---|---|
Location | 313 E. 1st Street, Alice, Texas |
Certified By | Medicare |
Services Offered | Nursing Care Physical Therapy Occupational Therapy Speech Pathology Medical Social Services Home Health Aide |
Medicare ID | 457873 |
Ownership Type | Proprietary |
Service Area Zip Codes | 78009, 78022, 78064, 78102, 78211, 78225, 78330, 78332, 78341, 78342, 78349, 78351, 78355, 78357, 78361, 78363, 78368, 78372, 78375, 78380, 78384, 78405, 78407, 78410, 78411, 78412, 78413, 78414, 78415, 78416, 78417, 78418 |
NPI Number | 1902851801 |
Organization Name | GARCIA VENTURES, INC. |
Doing Business As | UNITED HOME CARE |
Address | 2041 E Main St Ste 400b, Alice, TX 78332 |
Phone Number | 361-664-8908 |
News Archive
Researchers have published results of the largest trial of omega-3 to date, demonstrating a role for omega-3 supplements in lowering the risk of heart attack and CVD.
Zealand Pharma, a biopharmaceutical company dedicated to the discovery and development of innovative peptide drugs that recently listed on NASDAQ OMX, today announces the receipt of a EUR 500,000 (DKK 3.73 million) milestone payment as part of its license agreement with Helsinn Healthcare for the development of ZP1846 for the treatment of chemotherapy-induced diarrhoea. This milestone payment has no impact on the Company's outlook for 2010.
The two medicines (which are used in the treatment of AIDS) had been delisted by WHO in May this year due to non-compliance with international standards at the contract research organizations (CROs) hired by Cipla to conduct bioequivalence tests on the products.
The heart is the first organ to develop in the womb and the first cause of concern for many parents.
› Verified 4 days ago
Quality Rating: |
News Archive
Researchers have published results of the largest trial of omega-3 to date, demonstrating a role for omega-3 supplements in lowering the risk of heart attack and CVD.
Zealand Pharma, a biopharmaceutical company dedicated to the discovery and development of innovative peptide drugs that recently listed on NASDAQ OMX, today announces the receipt of a EUR 500,000 (DKK 3.73 million) milestone payment as part of its license agreement with Helsinn Healthcare for the development of ZP1846 for the treatment of chemotherapy-induced diarrhoea. This milestone payment has no impact on the Company's outlook for 2010.
The two medicines (which are used in the treatment of AIDS) had been delisted by WHO in May this year due to non-compliance with international standards at the contract research organizations (CROs) hired by Cipla to conduct bioequivalence tests on the products.
The heart is the first organ to develop in the womb and the first cause of concern for many parents.
› Verified 4 days ago
Quality Measure | Provider | National Avg. |
---|---|---|
How often the home health team began their patients’ care in a timely manner | 71.2 | 95.7 |
How often the home health team taught patients (or their family caregivers) about their drugs | 96.9 | 98.6 |
How often the home health team checked patients’ risk of falling | 98.6 | 99.6 |
How often the home health team checked patients for depression | 96.9 | 97.4 |
How often the home health team made sure that their patients have received a flu shot for the current flu season. | 60.3 | 78.7 |
How often the home health team made sure that their patients have received a pneumococcal vaccine (pneumonia shot). | 62.7 | 82.2 |
With diabetes, how often the home health team got doctor’s orders, gave foot care, and taught patients about foot care | 97.6 | 96.4 |
News Archive
Researchers have published results of the largest trial of omega-3 to date, demonstrating a role for omega-3 supplements in lowering the risk of heart attack and CVD.
Zealand Pharma, a biopharmaceutical company dedicated to the discovery and development of innovative peptide drugs that recently listed on NASDAQ OMX, today announces the receipt of a EUR 500,000 (DKK 3.73 million) milestone payment as part of its license agreement with Helsinn Healthcare for the development of ZP1846 for the treatment of chemotherapy-induced diarrhoea. This milestone payment has no impact on the Company's outlook for 2010.
The two medicines (which are used in the treatment of AIDS) had been delisted by WHO in May this year due to non-compliance with international standards at the contract research organizations (CROs) hired by Cipla to conduct bioequivalence tests on the products.
The heart is the first organ to develop in the womb and the first cause of concern for many parents.
› Verified 4 days ago
Quality Measure | Provider | National Avg. |
---|---|---|
How often patients got better at walking or moving around | 62.8 | 79.6 |
How often patients got better at getting in and out of bed | 50.2 | 81.1 |
How often patients got better at bathing | 53.8 | 82.3 |
How often patients’ breathing improved | 22.9 | 82.8 |
How often patients’ wounds improved or healed after an operation | - | 92.3 |
How often patients got better at taking their drugs correctly by mouth | 42.5 | 75 |
How often home health patients had to be admitted to the hospital | 13.7 | 15.4 |
How often patients receiving home health care needed urgent, unplanned care in the ER without being admitted | 12.6 | 13 |
How often physician-recommended actions to address medication issues were completely timely | 91.2 | 94 |
News Archive
Researchers have published results of the largest trial of omega-3 to date, demonstrating a role for omega-3 supplements in lowering the risk of heart attack and CVD.
Zealand Pharma, a biopharmaceutical company dedicated to the discovery and development of innovative peptide drugs that recently listed on NASDAQ OMX, today announces the receipt of a EUR 500,000 (DKK 3.73 million) milestone payment as part of its license agreement with Helsinn Healthcare for the development of ZP1846 for the treatment of chemotherapy-induced diarrhoea. This milestone payment has no impact on the Company's outlook for 2010.
The two medicines (which are used in the treatment of AIDS) had been delisted by WHO in May this year due to non-compliance with international standards at the contract research organizations (CROs) hired by Cipla to conduct bioequivalence tests on the products.
The heart is the first organ to develop in the womb and the first cause of concern for many parents.
› Verified 4 days ago
Question Type: | Rating by Patients |
---|---|
Health team gave care in a professional way | |
Health team communicated well with them | |
Health team discussed medicines, pain, and home safety | |
How patients rated overall care from agency |
News Archive
Researchers have published results of the largest trial of omega-3 to date, demonstrating a role for omega-3 supplements in lowering the risk of heart attack and CVD.
Zealand Pharma, a biopharmaceutical company dedicated to the discovery and development of innovative peptide drugs that recently listed on NASDAQ OMX, today announces the receipt of a EUR 500,000 (DKK 3.73 million) milestone payment as part of its license agreement with Helsinn Healthcare for the development of ZP1846 for the treatment of chemotherapy-induced diarrhoea. This milestone payment has no impact on the Company's outlook for 2010.
The two medicines (which are used in the treatment of AIDS) had been delisted by WHO in May this year due to non-compliance with international standards at the contract research organizations (CROs) hired by Cipla to conduct bioequivalence tests on the products.
The heart is the first organ to develop in the womb and the first cause of concern for many parents.
› Verified 4 days ago
The patient survey data of United Home Care is compared against the national average with the color code indicators: Better than National Average Worse than National AverageExperience Measure | Provider | National Avg. |
---|---|---|
Percent of patients who reported that their home health team gave care in a professional way | 93 | 88 |
Percent of patients who reported that their home health team communicated well with them | 89 | 85 |
Percent of patients who reported that their home health team discussed medicines, pain, and home safety with them | 86 | 83 |
Percent of patients who gave their home health agency a rating of 9 or 10 on a scale from 0 (lowest) to 10 (highest) | 92 | 84 |
Percent of patients who reported YES, they would definitely recommend the home health agency to friends and family | 87 | 78 |
News Archive
Researchers have published results of the largest trial of omega-3 to date, demonstrating a role for omega-3 supplements in lowering the risk of heart attack and CVD.
Zealand Pharma, a biopharmaceutical company dedicated to the discovery and development of innovative peptide drugs that recently listed on NASDAQ OMX, today announces the receipt of a EUR 500,000 (DKK 3.73 million) milestone payment as part of its license agreement with Helsinn Healthcare for the development of ZP1846 for the treatment of chemotherapy-induced diarrhoea. This milestone payment has no impact on the Company's outlook for 2010.
The two medicines (which are used in the treatment of AIDS) had been delisted by WHO in May this year due to non-compliance with international standards at the contract research organizations (CROs) hired by Cipla to conduct bioequivalence tests on the products.
The heart is the first organ to develop in the womb and the first cause of concern for many parents.
› Verified 4 days ago
Real Home Health Care Inc Location: 301 Lucero Street, Alice, Texas 78332 Ratings: NA Phone: (361) 668-3158 | |
Saldivar Home Health Inc Location: 618 Bluebonnet St, Alice, Texas 78332 Ratings: NA Phone: (361) 396-1204 | |
Del Cielo Home Care Services Location: 601 E Main St Suite 300, Alice, Texas 78332 Ratings: Phone: (361) 664-3484 | |
Carestat Provider Services Location: 171 Medical Center Blvd Unit D, Alice, Texas 78332 Ratings: Phone: (361) 241-4600 | |
Healthy Horizons Homecare Llc Location: 1006 E 6th St, Alice, Texas 78332 Ratings: Phone: (361) 396-1282 |